Track the 원텍 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 원텍 has recorded 86 insider filings. Market capitalisation: €625.6bn. The latest transaction was filed on 6 May 2026 (Purchase). Among the most active insiders: 최정윤. All data is openly available.
86
Insider Decl.
0
Thresholds
€3m
32 ops.
Buy Volume
€85,255
4 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 원텍 Buy (bullish), based on 3 analysts. Average price target: ₩10,667.
30Σ signal
Buys €3m€85,255 Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 1,377 of 26,034 companies
78.6
score / 100
Value
71
Quality
86
FCF yld9.8%
Earn yld6.9%
EV/EBITDA10.3x
ROE23%
Gross mgn67%
Net mgn22%
Debt/EBITDA0.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
